An understanding of endothelial progenitor cell (EPC) biology offers not only the intellectual rewards of understanding vascular repair but the potential to develop new therapeutic approaches that can be applied to coronary intervention. The field of EPC research is however fraught with problems relating to the characterisation of this cell type. This editorial reflect on the paper by Mills et al that adds further controversy to this area.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.